Inicio Zine News Intrommune Therapeutics Receives Formulation Patent Notice of Allowance

Intrommune Therapeutics Receives Formulation Patent Notice of Allowance

7
0
This Development Significantly Extends Patent Protection for Intrommune’s Lead Allergy Immunotherapy Product
This Development Significantly Extends Patent Protection for Intrommune’s Lead Allergy Immunotherapy Product